All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 6 of 45
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%Lack of Assurance of Sterility
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%Lack of Assurance of Sterility
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%Lack of Assurance of Sterility
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%Lack of Assurance of Sterility
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Dry Aid (povidone 0.68%Lack of Assurance of Sterility
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Dry Aid (povidone 0.68%Lack of Assurance of Sterility
-
Class IIofficial
Rohto-Mentholatum (Vietnam) Co., Ltd. recalls Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%Lack of Assurance of Sterility
-
Class IIofficial
Precision Dose Inc. recalls Glycopyrrolate Oral SolutionFailed Impurities/Degradation Specifications
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Major Pharmaceuticals recalls Levothyroxine Sodium TabletsSubpotent Drug
-
Class IIofficial
Rising Pharma Holding, Inc. recalls RisingPresence of Precipitate: medication was crystallizing and particles floating in the bottle
-
Class IIofficial
CareFusion 213, LLC recalls BD ChloraPrep ClearLack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
-
Class IIofficial
Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil TabletsFailed Dissolution Specifications; Olmesartan Medoxomil content below specifications
-
Class IIofficial
Chiesi USA, Inc. recalls CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL)Lack of Assurance of Sterility
-
Class IIIofficial
Supernus Pharmaceuticals, Inc. recalls Trokendi XRFailed Dissolution Specifications
-
Class IIofficial
Mylan Pharmaceuticals Inc recalls Mycophenolate Mofetil for Injection USPPresence of precipitate
-
Class Iofficial
Victory Medical Center Pharmacy recalls Glutathione (MDV)Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
-
Class IIIofficial
Ascend Laboratories, LLC recalls Dabigatran etexilate CapsulesFailed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
-
Class IIIofficial
Ascend Laboratories, LLC recalls Dabigatran etexilate CapsulesFailed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
-
Class IIofficial
Cipla USA, Inc. recalls Cinacalcet Hydrochloride TabletscGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class IIofficial
Cipla USA, Inc. recalls Cinacalcet Hydrochloride TabletscGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class IIofficial
Cipla USA, Inc. recalls Cinacalcet Hydrochloride TabletscGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class IIofficial
Lannett Company Inc. recalls Dextroamphetamine SaccharateLabeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
-
Class IIofficial
Bionpharma Inc. recalls Divalproex Sodium Delayed-Release TabletsPresence of Foreign Tablets/Capsules
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls CVS HealthSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls ClinereSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls QC Quality ChoiceSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls TopCare HealthSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls AUDIOLOGIST'S CHOICESubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls FAMILY WellnessSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls GOOD NEIGHBOR PHARMACYSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls LEADERSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls Foster & ThriveSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls meijerSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
Bell Pharmaceuticals, Inc recalls CAREoneSubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class IIofficial
QuVa Pharma, Inc. recalls Methohexital SodiumFailed Impurities/Degradation Specifications
-
Class IIofficial
Reliance Life Sciences Private Limited recalls Pemetrexed for Injection 100mg/VialLack of Sterility Assurance
-
Class IIofficial
Reliance Life Sciences Private Limited recalls Pemetrexed for Injection 500mg/VialLack of Sterility Assurance
-
Class IIofficial
Reliance Life Sciences Private Limited recalls Bortezomib for Injection 3.5mg/VialLack of Sterility Assurance
-
Class IIofficial
Reliance Life Sciences Private Limited recalls Azacitidine for Injection 100mg/VialLack of Sterility Assurance